Oral Chlorambucil for Extranodal, Marginal Zone, B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue of the Orbit
- 31 July 2006
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 113 (7) , 1209-1213
- https://doi.org/10.1016/j.ophtha.2006.01.057
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Regression of Ocular Adnexal Lymphoma AfterChlamydia Psittaci–Eradicating Antibiotic TherapyJournal of Clinical Oncology, 2005
- Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma*1Ophthalmology, 2004
- Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical OutcomeJournal of Clinical Oncology, 2003
- Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistanceOncogene, 2003
- Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT typeBlood, 2003
- Extranodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue of the head and neck areaCancer, 2003
- Typical genomic imbalances in primary MALT lymphoma of the orbitThe Journal of Pathology, 2003
- Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphomaBlood, 2003
- Primary orbital lymphomaThe Hematology Journal, 2002
- The Natural History of Initially Untreated Low-Grade Non-Hodgkin's LymphomasNew England Journal of Medicine, 1984